Quantcast

Latest Hydromorphone Stories

2011-06-30 17:03:00

READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ -- Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S.

2011-06-27 07:33:00

SAN CARLOS, Calif., June 27, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company developing next-generation abuse-resistant prescription drugs, today announced the appointment of Dr. Joseph Stauffer as Chief Medical Officer & VP, Corporate Strategy and Dr.

2011-06-23 15:45:00

CHADDS FORD, Pa., June 23, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan.

2011-06-23 15:00:00

SAN CARLOS, Calif., June 23, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company developing next-generation abuse-resistant prescription drugs, today announced positive results from a Phase I human proof-of-concept (hPOC) study of its hydromorphone (HM) Bio-Activated Molecular Delivery(TM) (Bio-MD(TM)) product candidate, PF329.

2011-05-31 06:30:00

REDWOOD CITY, Calif., May 31, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.


Word of the Day
abactinal
  • Pertaining to the surface or end opposite to the mouth in a radiate animal.
The word 'abactinal' comes from a Greek root meaning 'ray' and a Latin prefix meaning 'away'.
Related